Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Panitumumab and Capecitabine With Radiation in Rectal Cancer
NCT00967655Phase 2Unknown
- Sponsor
- Loma Linda Oncology Medical Group
- Start
- Jul 2009
- Primary completion
- Jul 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in rectal cancer, sponsored by Loma Linda Oncology Medical Group. Status: unknown.
02
Drugs
panitumumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00967655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00967655.